Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/16/c5/e4/16c5e419-b7bd-a29a-4eab-03b8be7a6bcb/mza_14462280790105379015.jpg/600x600bb.jpg
The BioInsights Podcast
BioInsights
58 episodes
2 weeks ago
In this interview, Róisin McGuigan, Editor, Nucleic Acid Insights, and Jesse Erasmus, Director of Virology at HDT Bio, discuss current challenges and opportunities in RNA safety, manufacturing, and targeted delivery, and the key ongoing obstacles facing viral and LNP-based delivery modalities.
Show more...
Life Sciences
Business,
Science
RSS
All content for The BioInsights Podcast is the property of BioInsights and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this interview, Róisin McGuigan, Editor, Nucleic Acid Insights, and Jesse Erasmus, Director of Virology at HDT Bio, discuss current challenges and opportunities in RNA safety, manufacturing, and targeted delivery, and the key ongoing obstacles facing viral and LNP-based delivery modalities.
Show more...
Life Sciences
Business,
Science
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/16/c5/e4/16c5e419-b7bd-a29a-4eab-03b8be7a6bcb/mza_14462280790105379015.jpg/600x600bb.jpg
Navigating genomics and transcriptomics in the immuno-oncology space
The BioInsights Podcast
20 minutes
1 year ago
Navigating genomics and transcriptomics in the immuno-oncology space
Lauren Coyle, Commissioning Editor, Immuno-Oncology Insights, interviews Katie Campbell, Postdoctoral Fellow, Cancer Research Institute, about her current research on genomics, transcriptomics, and spatial profiling to address challenges in the I-O field.
The BioInsights Podcast
In this interview, Róisin McGuigan, Editor, Nucleic Acid Insights, and Jesse Erasmus, Director of Virology at HDT Bio, discuss current challenges and opportunities in RNA safety, manufacturing, and targeted delivery, and the key ongoing obstacles facing viral and LNP-based delivery modalities.